Delphia (Usa) Inc. Mirum Pharmaceuticals, Inc. Transaction History
Delphia (Usa) Inc.
- $0
- Q3 2024
Shares
2 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$292 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$199 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$153 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$144 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$137 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.64B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...